The victim count from last year's data breach has increased significantly. The number of victims impacted by the Change ...

Q4 2024 Earnings Call Transcript January 30, 2025 Cigna Corporation misses on earnings expectations. Reported EPS is $6.64 ...

Mizuho Securities analyst Ann Hynes has maintained their bullish stance on CI stock, giving a Buy rating yesterday.Invest with Confidence: ...

The general mood among these heavyweight investors is divided, with 41% leaning bullish and 41% bearish. Among these notable options, 3 are puts, totaling $371,983, and 9 are calls, amounting to ...

The villains were injectable specialty drugs like Keytruda and inpatient surgical procedures for seriously ill patients.

Raymond James analyst John Ransom lowered the firm’s price target on Cigna (CI) to $360 from $415 and keeps a Strong Buy rating on the shares.

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

Cigna Group inc. (NYSE: CI) shares are rebounding Friday after dropping on Thursday following a fourth-quarter earnings miss.

Bloomfield-based Cigna announced this week a new initiative that aims to reduce out-of-pocket prescription-drug costs and make those costs more transparent.

Shares of Cigna Group slid after the health insurer warned that higher health-care costs in one insurance unit weighed on profitability. Insurers saw profit margins soar in the pandemic as insurees ...

Cigna Corp (NYSE:CI) reported its fourth-quarter 2024 earnings, revealing a notable miss on earnings per share (EPS) despite surpassing revenue expectations. The company's stock reacted negatively in ...

Icarus Behavioral Health Nevada announces the accreditation of its comprehensive mental health programs in Las Vegas, ...